Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma
- First Posted Date
- 2009-01-01
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 94
- Registration Number
- NCT00816634
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-12-30
- Last Posted Date
- 2009-06-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 47
- Registration Number
- NCT00815334
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)
- First Posted Date
- 2008-12-30
- Last Posted Date
- 2008-12-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 114
- Registration Number
- NCT00815568
- Locations
- 🇰🇷
Dong Hwan Kim, Seoul, Korea, Republic of
Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
Completed
- Conditions
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2009-03-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT00803517
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome
Completed
- Conditions
- First Posted Date
- 2008-12-02
- Last Posted Date
- 2008-12-02
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT00800852
High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00798811
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 258
- Registration Number
- NCT00795782
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2013-02-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 258
- Registration Number
- NCT00794014
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00793845
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation
Phase 2
Completed
- Conditions
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT00793351
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath